Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

ClinicalTrials.gov ID: NCT00121641

Public ClinicalTrials.gov record NCT00121641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 12:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is more effective than placebo as a treatment for type 2 diabetic subjects who are not sufficiently controlled with diet and exercise

Study identification

NCT ID
NCT00121641
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,035 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 77 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2005 (Type not available)
Primary completion
Aug 2006 (Actual)
Completion
Feb 2010 (Actual)
Last update posted
Apr 3, 2015

2005 – 2010

United States locations

U.S. sites
83
U.S. states
31
U.S. cities
83
Facility City State ZIP Site status
Local Institution Anniston Alabama — —
Local Institution Birmingham Alabama — —
Local Institution Calera Alabama — —
Local Institution Jonesboro Arizona — —
Local Institution Mesa Arizona — —
Local Institution Pheonix Arizona — —
Local Institution Little Rock Arkansas — —
Local Institution Anaheim California — —
Local Institution Fountain Valley California — —
Local Institution Fresno California — —
Local Institution Long Beach California — —
Local Institution Los Angeles California — —
Local Institution Northridge California — —
Local Institution Rolling Hills Estates California — —
Local Institution Sacramento California — —
Local Institution Santa Ana California — —
Local Institution Spring Valley California — —
Local Institution Tustin California — —
Local Institution Castle Rock Colorado — —
Local Institution Denver Colorado — —
Local Institution Loveland Colorado — —
Local Institution Altamonte Springs Florida — —
Local Institution Chipley Florida — —
Local Institution Cocoa Beach Florida — —
Local Institution Coral Gables Florida — —
Local Institution Fort Lauderdale Florida — —
Local Institution Jupiter Florida — —
Local Institution Kissimmee Florida — —
Local Institution Marianna Florida — —
Local Institution New Port Richey Florida — —
Local Institution Ocala Florida — —
Local Institution West Palm Beach Florida — —
Local Institution Vernon Hills Illinois — —
Local Institution Dubuque Iowa — —
Local Institution Iowa City Iowa — —
Local Institution Waterloo Iowa — —
Local Institution Wichita Kansas — —
Local Institution Lexington Kentucky — —
Local Institution Munfordville Kentucky — —
Local Institution New Orleans Louisiana — —
Local Institution West Monroe Louisiana — —
Local Institution Baltimore Maryland — —
Local Institution Chester Maryland — —
Local Institution Prince Frederick Maryland — —
Local Institution Ayer Massachusetts — —
Local Institution Boston Massachusetts — —
Local Institution Rolling Fork Mississippi — —
Local Institution Kansas City Missouri — —
Local Institution Springfield Missouri — —
Local Institution St Louis Missouri — —
Local Institution Kalispell Montana — —
Local Institution Omaha Nebraska — —
Local Institution Las Vegas Nevada — —
Local Institution Middletown New Jersey — —
Local Institution Toms River New Jersey — —
Local Institution Cooperstown New York — —
Local Institution Greensboro North Carolina — —
Local Institution Huntersville North Carolina — —
Local Institution Sparta North Carolina — —
Local Institution Statesville North Carolina — —
Local Institution Winston-Salem North Carolina — —
Local Institution Athens Ohio — —
Local Institution Franklin Ohio — —
Local Institution Oklahoma City Oklahoma — —
Local Institution Tulsa Oklahoma — —
Local Institution Portland Oregon — —
Local Institution Fleetwood Pennsylvania — —
Local Institution Philadelphia Pennsylvania — —
Local Institution Pittsburgh Pennsylvania — —
Local Institution Charleston South Carolina — —
Local Institution Bristol Tennessee — —
Local Institution Morristown Tennessee — —
Local Institution Bryan Texas — —
Local Institution Dallas Texas — —
Local Institution Fort Worth Texas — —
Local Institution Houston Texas — —
Local Institution San Antonio Texas — —
Local Institution Temple Texas — —
Local Institution Texarkana Texas — —
Local Institution The Colony Texas — —
Local Institution Salt Lake City Utah — —
Local Institution Virginia Beach Virginia — —
Local Institution Olympia Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00121641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2015 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00121641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →